Halozyme Therapeutics Inc (HALO)
44.32
+0.97
(+2.24%)
USD |
NASDAQ |
May 31, 16:00
44.32
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Profit Margin (Quarterly): 39.22% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 39.22% |
December 31, 2023 | 37.12% |
September 30, 2023 | 37.88% |
June 30, 2023 | 33.82% |
March 31, 2023 | 24.43% |
December 31, 2022 | 31.79% |
September 30, 2022 | 29.49% |
June 30, 2022 | 14.89% |
March 31, 2022 | 51.25% |
December 31, 2021 | 65.46% |
September 30, 2021 | |
June 30, 2021 | 67.02% |
March 31, 2021 | 31.34% |
December 31, 2020 | 60.12% |
September 30, 2020 | 55.43% |
June 30, 2020 | 46.75% |
March 31, 2020 | -24.07% |
December 31, 2019 | -64.10% |
September 30, 2019 | -54.11% |
June 30, 2019 | -37.36% |
March 31, 2019 | 3.15% |
December 31, 2018 | -3.53% |
September 30, 2018 | -109.0% |
June 30, 2018 | -65.03% |
March 31, 2018 | -88.95% |
Date | Value |
---|---|
December 31, 2017 | 65.35% |
September 30, 2017 | 4.31% |
June 30, 2017 | -91.15% |
March 31, 2017 | -111.3% |
December 31, 2016 | -70.22% |
September 30, 2016 | -90.87% |
June 30, 2016 | -80.62% |
March 31, 2016 | -46.63% |
December 31, 2015 | 8.27% |
September 30, 2015 | -117.7% |
June 30, 2015 | 6.96% |
March 31, 2015 | -80.94% |
December 31, 2014 | -17.36% |
September 30, 2014 | -138.8% |
June 30, 2014 | -88.51% |
March 31, 2014 | -221.9% |
December 31, 2013 | -175.9% |
September 30, 2013 | -120.5% |
June 30, 2013 | -158.5% |
March 31, 2013 | -163.0% |
December 31, 2012 | -20.22% |
September 30, 2012 | -375.0% |
June 30, 2012 | -180.8% |
March 31, 2012 | -203.2% |
December 31, 2011 | -763.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.10%
Minimum
Dec 2019
67.02%
Maximum
Jun 2021
23.49%
Average
33.82%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
Novavax Inc | -157.2% |
Denali Therapeutics Inc | -- |
AIM ImmunoTech Inc | -14.54K% |
Protalix BioTherapeutics Inc | -122.6% |
Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 219.1% |
Return on Assets | 17.76% |
Return on Invested Capital | 19.40% |
Gross Profit Margin (Quarterly) | 85.54% |
Operating Margin (Quarterly) | 48.78% |
Return on Net Operating Assets | 23.45% |